Cancer Clinical Trial
Official title:
Palliative Care in General Practice: Cancer Patients' and Carers' Experience of Their General Practitioner's (GP's) Role
Study Title: Palliative care in general practice: cancer patients' and carers' experience of
their GP's role
Study Design: Qualitative interview study
Study Participants: Adult patients with cancer and palliative care needs, accompanied by
their carers
Planned Sample Size: Up to 30 interviews with patients +/- their carers
Planned Study Period: October 2017 - December 2018
Research Question: What experience do adults with cancer, and carers, have of their GP's
involvement in palliative care provision?
Participants will be invited and recruited to the study from St Joseph's Hospice in Hackney
(single centre study). Patients with cancer that are either attending the day centre service
at St Joseph's or being visited at home by the community specialist palliative care
nursing/medical team based at St Joseph's Hospice; will be approached by their direct
clinical care staff. (Some of the direct clinical care team are National Health Service (NHS)
staff and some care is commissioned by the NHS despite St Joseph's Hospice being a non-NHS
site). Staff will initiate discussion about the project, and will assess for both mental and
physical capacity to participate.
Dr Emilie Green (EG) will then contact the potential participants by phone or in person (if
they have previously given verbal consent for her to join their usual clinical staff on a
home visit or when they are attending the day centre). The project will be discussed with
each potential participant, and EG will answer any questions they may have, will assess for
mental and physical capacity, and will arrange a mutually convenient time and location to
meet for the interview.
Before starting the interview, EG will again make time to clarify any questions each
participant may have. She will ask each participant to date/sign three consent forms before
starting the interview (one for EG, one for the participant, and one for their notes at St
Joseph's Hospice). If a joint interview is undertaken with a patient and their carer; both
parties will individually sign their own consent forms. She will then ask questions relating
to sociodemographic data (recording this on the Personal Information Sheet) e.g. age, living
situation and diagnosis before starting the interview. The interviews will each last at least
30 minutes.
If participants decide that they would like a telephone interview, the process will be
slightly different. EG will send three consent forms to each prospective participant (one for
them to keep, and two for them to date/sign and send back by post) in a stamped addressed
envelope. If the forms are not received within 3 weeks, EG will follow up with a phone call
to the prospective participant, to clarify whether they still wish to participate. Only after
she receives the two dated/signed consent forms will EG arrange a time with them for the
telephone interview. She will then phone the participant from a private location that she
does not share with other colleagues. She will collect sociodemographic information (which
will be recorded on the Personal Information Sheet) before starting the interview (which will
last at least 30 minutes.)
Qualitative data will be obtained through semi-structured interviews with adults with cancer
and palliative care needs. Patients will be invited to bring their carer to the interview. EG
will conduct and transcribe up to 30 audio-recorded semi-structured interviews, which will be
carried out at the patient's preferred location (either at home, over the phone, or in a
pre-booked room at St Joseph's Hospice). EG will ask questions relating to sociodemographic
data (recording this on the Personal Information Sheet) prior to starting the interview.
EG will transcribe all interviews verbatim. Data will be analysed thematically and will
adhere to the principles of the Framework Analysis developed by Ritchie and Spencer.
Recurring themes and concepts will be identified using a constant comparative approach. Any
contributions made by carers will be included and analysed as 'added value' data.This will
enable us to explore if and how carers' perspectives contribute to our understanding of
patient experience of their GP's involvement in palliative care.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|